Rheos Medicines
Latest round
- Series A
Last raised
- Mar 2018
Total raised
- $60M
Investors
- 1
About Rheos Medicines
Rheos Medicines, Inc. specializes in innovative drug delivery systems aimed at enhancing therapeutic efficacy and patient outcomes.Rheos Medicines, Inc. develops advanced drug delivery systems and was founded in 2017 in Cambridge, US.00 mn.RheosRx specializes in developing innovative solutions aimed at enhancing patient outcomes through their flagship product, a proprietary drug delivery system designed to optimize the therapeutic effect of medications. This technology focuses on addressing specific medical conditions by improving the bioavailability and targeted delivery of active pharmaceutical ingredients. The company’s offerings are tailored primarily to healthcare providers, including hospitals and clinics, as well as directly to patients who require specialized treatment options. The products have been strategically launched in key geographical markets such as North America and Europe, where there is a significant demand for advanced medical therapies.RheosRx's revenue model is primarily structured around direct sales and partnerships with healthcare institutions that utilize their drug delivery systems. The company engages in B2B transactions, offering its products to hospitals and clinics seeking innovative solutions for patient care. These transactions are structured as contractual agreements, where healthcare providers order products based on their specific needs. RheosRx offers a tiered pricing plan that accommodates different scales of purchase, allowing for flexibility based on order volume.Rheos Medicines, Inc. The company is currently designing new drug delivery products aimed at improving patient outcomes, with launches expected in the coming years. RheosRx is targeting expansion into additional markets in Europe and Asia by 2025 to meet rising demand for advanced therapeutic solutions.
Who invested in Rheos Medicines
1 investor across 1 round
See all investors in Rheos Medicines
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 22, 2018
Amount
$60M
Investors
Questions about Rheos Medicines
Who invested in Rheos Medicines?
Rheos Medicines has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rheos Medicines raised?
Rheos Medicines has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Rheos Medicines last raise money?
Rheos Medicines's most recent round on record is a Series A, in Mar 2018.
What does Rheos Medicines do?
Rheos Medicines is a pharmaceuticals company.
Where is Rheos Medicines headquartered?
Rheos Medicines is headquartered in Cambridge, US.
Which VCs invest in companies like Rheos Medicines?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Rheos Medicines's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Rheos Medicines? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.